Another week, another tariff deadline extension. There is every indication that the negotiations between the US and the EU are far from being over.
The trade deal announced this week by the US and the EU places Britain and Europe on different footings. While it also brings advantages for Northern Ireland, significant uncertainty remains.
The White House has steamrolled its way to higher tariffs with key partners Japan and the EU, whose further promises of American purchases and investments don't mean much. This is paving the way for US action on the dollar and financial bodies.
The timing could hardly be worse to make decisions on the fiscal space or capital commitments. The Government’s big announcements are really just holding positions.
The Revenue Commissioners has failed to secure its preferred nominee as liquidator of the Kerry-based drinks company, which collapsed last week with debts of over €4m and the loss of 50 jobs.
As the threat of sweeping US tariffs looms, Irish exporters and multinationals face an uncertain path. The Government has some big decisions to make.
How should a pharma multinational respond to the uncertainty unleashed by the Trump administration? Invest more in Ireland, the contact-lens and eye-drop giant appears to have decided.
The state agency’s incoming CEO Jenny Melia is pushing companies to centralise R&D at home and avoid reliance on a dominant export market. After Brexit, the diversification strategy now becomes a playbook for dealing with the US.
Days after its main lender installed receivers over the whiskey maker, two minority shareholders have petitioned the High Court for court protection from creditors in an effort to restructure the business.
The EU’s free trade agreement with South American countries is 25 years in the making. There’s a final effort in play to get it over the line but Ireland’s position is in flux.
© 2025 Currency Media Limited
